SANARA MEDTECH INC (SMTI) Fundamental Analysis & Valuation

NASDAQ:SMTI • US79957L1008

Current stock price

18.93 USD
-0.29 (-1.51%)
Last:

This SMTI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. SMTI Profitability Analysis

1.1 Basic Checks

  • SMTI had negative earnings in the past year.
  • SMTI had a positive operating cash flow in the past year.
  • In the past 5 years SMTI always reported negative net income.
  • SMTI had negative operating cash flow in 4 of the past 5 years.
SMTI Yearly Net Income VS EBIT VS OCF VS FCFSMTI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -10M -20M -30M

1.2 Ratios

  • The Return On Assets of SMTI (-51.50%) is worse than 69.52% of its industry peers.
  • With a Return On Equity value of -632.54%, SMTI is not doing good in the industry: 88.77% of the companies in the same industry are doing better.
  • SMTI's Return On Invested Capital of 5.41% is fine compared to the rest of the industry. SMTI outperforms 76.47% of its industry peers.
Industry RankSector Rank
ROA -51.5%
ROE -632.54%
ROIC 5.41%
ROA(3y)-22.76%
ROA(5y)-20.61%
ROE(3y)-222.22%
ROE(5y)-142.3%
ROIC(3y)N/A
ROIC(5y)N/A
SMTI Yearly ROA, ROE, ROICSMTI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -200 -400 -600

1.3 Margins

  • With a decent Operating Margin value of 3.61%, SMTI is doing good in the industry, outperforming 68.98% of the companies in the same industry.
  • Looking at the Gross Margin, with a value of 92.71%, SMTI belongs to the top of the industry, outperforming 98.40% of the companies in the same industry.
  • In the last couple of years the Gross Margin of SMTI has remained more or less at the same level.
Industry RankSector Rank
OM 3.61%
PM (TTM) N/A
GM 92.71%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.48%
GM growth 5Y0.68%
SMTI Yearly Profit, Operating, Gross MarginsSMTI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. SMTI Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so SMTI is destroying value.
  • SMTI has more shares outstanding than it did 1 year ago.
  • SMTI has more shares outstanding than it did 5 years ago.
  • SMTI has a worse debt/assets ratio than last year.
SMTI Yearly Shares OutstandingSMTI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M 8M
SMTI Yearly Total Debt VS Total AssetsSMTI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M

2.2 Solvency

  • SMTI has an Altman-Z score of 1.96. This is not the best score and indicates that SMTI is in the grey zone with still only limited risk for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 1.96, SMTI is in line with its industry, outperforming 57.75% of the companies in the same industry.
  • The Debt to FCF ratio of SMTI is 21.51, which is on the high side as it means it would take SMTI, 21.51 years of fcf income to pay off all of its debts.
  • With a decent Debt to FCF ratio value of 21.51, SMTI is doing good in the industry, outperforming 67.91% of the companies in the same industry.
  • A Debt/Equity ratio of 7.74 is on the high side and indicates that SMTI has dependencies on debt financing.
  • SMTI's Debt to Equity ratio of 7.74 is on the low side compared to the rest of the industry. SMTI is outperformed by 89.30% of its industry peers.
Industry RankSector Rank
Debt/Equity 7.74
Debt/FCF 21.51
Altman-Z 1.96
ROIC/WACC0.63
WACC8.58%
SMTI Yearly LT Debt VS Equity VS FCFSMTI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10M 20M 30M 40M

2.3 Liquidity

  • A Current Ratio of 1.80 indicates that SMTI should not have too much problems paying its short term obligations.
  • SMTI has a Current ratio of 1.80. This is in the lower half of the industry: SMTI underperforms 68.45% of its industry peers.
  • SMTI has a Quick Ratio of 1.59. This is a normal value and indicates that SMTI is financially healthy and should not expect problems in meeting its short term obligations.
  • SMTI's Quick ratio of 1.59 is in line compared to the rest of the industry. SMTI outperforms 41.18% of its industry peers.
Industry RankSector Rank
Current Ratio 1.8
Quick Ratio 1.59
SMTI Yearly Current Assets VS Current LiabilitesSMTI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. SMTI Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 59.47% over the past year.
  • SMTI shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 19.01%.
  • The Revenue has been growing by 45.91% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)59.47%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%150%
Revenue 1Y (TTM)19.01%
Revenue growth 3Y31.03%
Revenue growth 5Y45.91%
Sales Q2Q%4.72%

3.2 Future

  • Based on estimates for the next years, SMTI will show a very strong growth in Earnings Per Share. The EPS will grow by 108.86% on average per year.
  • SMTI is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 14.06% yearly.
EPS Next Y243.51%
EPS Next 2Y108.86%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year15.65%
Revenue Next 2Y14.06%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
SMTI Yearly Revenue VS EstimatesSMTI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M 80M 100M
SMTI Yearly EPS VS EstimatesSMTI Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 0.5 -0.5 1 -1

More info and screens

Find the best growth stocksShow best growing peers

4

4. SMTI Valuation Analysis

4.1 Price/Earnings Ratio

  • SMTI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • A Price/Forward Earnings ratio of 28.55 indicates a quite expensive valuation of SMTI.
  • Based on the Price/Forward Earnings ratio, SMTI is valued a bit cheaper than 73.26% of the companies in the same industry.
  • SMTI's Price/Forward Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 22.23.
Industry RankSector Rank
PE N/A
Fwd PE 28.55
SMTI Price Earnings VS Forward Price EarningsSMTI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40

4.2 Price Multiples

  • SMTI's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. SMTI is cheaper than 71.12% of the companies in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of SMTI indicates a somewhat cheap valuation: SMTI is cheaper than 69.52% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 81.21
EV/EBITDA 26.82
SMTI Per share dataSMTI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • SMTI's earnings are expected to grow with 108.86% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y108.86%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. SMTI Dividend Analysis

5.1 Amount

  • No dividends for SMTI!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

SMTI Fundamentals: All Metrics, Ratios and Statistics

SANARA MEDTECH INC

NASDAQ:SMTI (4/27/2026, 8:18:10 PM)

18.93

-0.29 (-1.51%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)03-24
Earnings (Next)05-12
Inst Owners21.35%
Inst Owner Change0.52%
Ins Owners9.09%
Ins Owner Change-0.94%
Market Cap173.59M
Revenue(TTM)103.14M
Net Income(TTM)-37.56M
Analysts82.86
Price Target36.72 (93.98%)
Short Float %7.61%
Short Ratio3.7
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)60.63%
Min EPS beat(2)-19.79%
Max EPS beat(2)141.04%
EPS beat(4)3
Avg EPS beat(4)47.51%
Min EPS beat(4)-19.79%
Max EPS beat(4)141.04%
EPS beat(8)4
Avg EPS beat(8)-12.84%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-2.24%
Min Revenue beat(2)-3.03%
Max Revenue beat(2)-1.44%
Revenue beat(4)1
Avg Revenue beat(4)-1.48%
Min Revenue beat(4)-3.03%
Max Revenue beat(4)0.69%
Revenue beat(8)3
Avg Revenue beat(8)-0.2%
Revenue beat(12)4
Avg Revenue beat(12)-2.3%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-10%
PT rev (3m)-12.2%
EPS NQ rev (1m)-134.61%
EPS NQ rev (3m)-160%
EPS NY rev (1m)0%
EPS NY rev (3m)-47.37%
Revenue NQ rev (1m)-2.15%
Revenue NQ rev (3m)-2.85%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.64%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 28.55
P/S 1.68
P/FCF 81.21
P/OCF 25.58
P/B 29.23
P/tB N/A
EV/EBITDA 26.82
EPS(TTM)-0.46
EYN/A
EPS(NY)0.66
Fwd EY3.5%
FCF(TTM)0.23
FCFY1.23%
OCF(TTM)0.74
OCFY3.91%
SpS11.25
BVpS0.65
TBVpS-1.78
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -51.5%
ROE -632.54%
ROCE 6.85%
ROIC 5.41%
ROICexc 7.79%
ROICexgc 18.97%
OM 3.61%
PM (TTM) N/A
GM 92.71%
FCFM 2.07%
ROA(3y)-22.76%
ROA(5y)-20.61%
ROE(3y)-222.22%
ROE(5y)-142.3%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.48%
GM growth 5Y0.68%
F-Score4
Asset Turnover1.41
Health
Industry RankSector Rank
Debt/Equity 7.74
Debt/FCF 21.51
Debt/EBITDA 6
Cap/Depr 117.82%
Cap/Sales 4.51%
Interest Coverage 1.11
Cash Conversion 88.51%
Profit Quality N/A
Current Ratio 1.8
Quick Ratio 1.59
Altman-Z 1.96
F-Score4
WACC8.58%
ROIC/WACC0.63
Cap/Depr(3y)43.23%
Cap/Depr(5y)57.27%
Cap/Sales(3y)1.73%
Cap/Sales(5y)1.98%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)59.47%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%150%
EPS Next Y243.51%
EPS Next 2Y108.86%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)19.01%
Revenue growth 3Y31.03%
Revenue growth 5Y45.91%
Sales Q2Q%4.72%
Revenue Next Year15.65%
Revenue Next 2Y14.06%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y195.74%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y944.53%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y28615.1%
OCF growth 3YN/A
OCF growth 5YN/A

SANARA MEDTECH INC / SMTI Fundamental Analysis FAQ

What is the fundamental rating for SMTI stock?

ChartMill assigns a fundamental rating of 3 / 10 to SMTI.


What is the valuation status of SANARA MEDTECH INC (SMTI) stock?

ChartMill assigns a valuation rating of 4 / 10 to SANARA MEDTECH INC (SMTI). This can be considered as Fairly Valued.


Can you provide the profitability details for SANARA MEDTECH INC?

SANARA MEDTECH INC (SMTI) has a profitability rating of 2 / 10.


How financially healthy is SANARA MEDTECH INC?

The financial health rating of SANARA MEDTECH INC (SMTI) is 3 / 10.